A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Severe Plaque Psoriasis

NCT05020249 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Plaque Psoriasis

Interventions

DRUG: bimekizumab
OTHER: Placebo

Sponsor

UCB Biopharma SRL